CFO
VCYT icon

CVA Family Office’s Veracyte VCYT Stock Holding History

CVA Family Office’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.05K Buy
69
+42
+156% +$1.76K ﹤0.01% 1336
2026
Q1 		$870 Buy
27
+3
+13% +$111 ﹤0.01% 1674
2025
Q4 		$1.01K Hold
24
– – ﹤0.01% 1099
2025
Q3 		$824 Hold
24
– – ﹤0.01% 1157
2025
Q2 		$649 Hold
24
– – ﹤0.01% 1169
2025
Q1 		$712 Hold
24
– – ﹤0.01% 1165
2024
Q4 		$950 Hold
24
– – ﹤0.01% 1103
2024
Q3 		$817 Hold
24
– – ﹤0.01% 1106
2024
Q2 		$520 Buy
+24
New +$505 ﹤0.01% 1191

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

CVA Family Office's VCYT Position: Q2 2026 in Review

CVA Family Office increased its Veracyte (VCYT) stake by 156% in Q2 2026, buying an estimated $1.76K and bringing the position to 69 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

CVA Family Office first reported a position in VCYT in Q2 2024 and has held it in 9 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • CVA Family Office held 69 shares of Veracyte worth $4.05K as of Q2 2026.
  • CVA Family Office bought 42 Veracyte shares in Q2 2026, an estimated $1.76K.
  • Veracyte made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1336 holding.
  • CVA Family Office first reported a position in Veracyte in Q2 2024 and has held it in 9 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.